<unk>  is indicated for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19.
Molnupiravir
Balapiravir
Odalasvir
Saquinavir
Remdesivir
Coronavir
Favipiravir
Maribavir